3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
4
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Precancerous Conditions
2
Lung Neoplasms
2
Vascular Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Radiation-induced Injuries in Patients With Rectal Cancer
1
Radiation Injuries
1
Neurotoxicity Syndromes
1
Neoplasms
1
Myocardial Ischemia
1
Myocardial Infarction
1
Heart Diseases
1
Head and Neck Neoplasms
1
Depression
1
Delirium
1
Coronary Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cerebrovascular Disorders
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Adenomatous Polyps
1
Interventions
Fluorouracil
131
Leucovorin
127
Oxaliplatin
93
Bevacizumab
86
Irinotecan
74
Capecitabine
63
Cetuximab
47
Folfox protocol
32
Panitumumab
18
regorafenib
16
trifluridine tipiracil drug combination
15
Drug Therapy
14
Chemotherapy, Adjuvant
13
IFL protocol
10
Floxuridine
10
Radiotherapy
9
Tegafur
7
Neoadjuvant Therapy
7
Levoleucovorin
7
Laparoscopy
7
Aspirin
7
pembrolizumab
6
atezolizumab
6
Trifluridine
6
Celecoxib
6
XELOX
5
Mitomycin
5
Colonoscopy
5
tipiracil
4
sintilimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Colorectal Neoplasms
×
Vitamin E
×
Clear all
NCT00706121
2019-12-16
ACP
SWOG Cancer Research Network
Phase 3
Completed
8,094 enrolled
23 charts